Hosted on MSN1mon
Liver lesions at risk of transformation into hepatocellular carcinoma in cirrhotic patients: Study
This imaging technique has improved the diagnostic accuracy for small HCC lesions (<2 cm) and reduced recurrence rates, enhancing overall patient prognosis. Moreover, the integration of diffusion ...
Medscape27d
Is SBRT Better Than Ablation for Small Liver Cancer?
In patients with recurrent small hepatocellular carcinoma (HCC), stereotactic body radiotherapy (SBRT) demonstrated superior local progression-free survival (PFS) and tumor control at 3 years ...
Targeted Oncology58m
FDA Fast Tracks Amezalpat for HCC Treatment
Amezalpat received fast track designation from the FDA for the treatment of patients with hepatocellular carcinoma.
Tempest Granted Fast Track Designation from the U.S. Food and Drug Administration for Amezalpat to Treat Patients with Hepatocellular Carcinoma
Fast Track Designation highlights potential of amezalpat to address unmet need for patients with HCCAmezalpat builds momentum with both ...
Medscape12d
Meta-analysis of Radiofrequency Ablation versus Hepatic Resection for Small Hepatocellular Carcinoma
Background: There is no clear consensus on the better therapy [radiofrequency ablation (RFA) versus hepatic resection (HR)] for small hepatocellular carcinoma (HCC) eligible for surgical treatments.